New asthma drug shows promise in phase 2 trial
Disease control
Ongoing
This study tests a new medicine, WIN378, for adults with moderate or severe asthma. WIN378 blocks a protein that causes lung inflammation, aiming to improve asthma control. About 136 participants will receive either WIN378 or a placebo to check safety, dosing, and effects on brea…
Phase: PHASE2 • Sponsor: Windward Bio • Aim: Disease control
Last updated May 13, 2026 16:03 UTC